November 13, 2026 9:55 PM
NPPA directs strict monitoring of revised prices of 137 anti-cancer drugs
The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, has directed strict monitoring of the implementation of Trade Margin Rationalisation (TMR) on 137 non-scheduled anti-cancer drugs, with revised maximum retail prices (MRPs) coming into effect from November 9, 2026. The revised prices were notified through a Gazette order dated October 17, 2026, the authority said. The latest revised price lists, based on submissions received from pharmaceutical compa...


